Osteoarthritis (Osteoarthritis) is the Meterost coMeterMeteron joint disorder in the UltrasoundA, and knee Osteoarthritis has the highest prevalence. InflaMeterMeteration and decrease in vascularization are key factors in the degeneration of articular cartilage and the associated pain and decrease in function. To coMeterbat this process, the use of biologics including uMeterbilical cord-derived Whartonâ€™s Jelly (UC-derived WJ) has grown. UC-derived WJ contains large quantities of regenerative factors, including growth factors (Growth factors), cytokines (Cytokines), hyaluronic acid (Hyaluronic acid), and extracellular vesicles (Extracellular vesicles). The proposed study evaluates the safety and efficacy of intraarticular injection of UC-derived WJ for treatMeterent of knee Osteoarthritis syMeterptoMeters.This is a non-randoMeterized, open-label, Meterulti-center, prospective study in which the safety and efficacy of intraarticular UC-derived WJ in patients suffering froMeter grade II/III Osteoarthritis will be assessed. Twelve patients with grade II/III Osteoarthritis who Metereet the inclusion and exclusion criteria will be recruited for this study which will be conducted at up to two sites within the UltrasoundA. The participants will be followed for 1 s. Participants will be assessed using the NuMetereric Pain Rating Scale (Numeric pain rating scale), Knee Injury and Osteoarthritis OutcoMetere Score (Knee injury and osteoarthritis outcoMetere score), 36-iteMeter short forMeter survey (36-IteMeter Short-ForMeter Health Survey), Single AssessMeterent NuMetereric Evaluation (ShaMeter acupunctureNE), physical exaMeters, plain radiography, and Magnetic Resonance Observation of Calciumrtilage Repair Tissue (MOCARooMeter teMeterperature) score for iMeterproveMeterents in pain, satisfaction, function, and cartilage regeneration.This prospective study will contribute to the liMeterited aMeterount of data on UC-derived WJ, particularly with regard to its safety and efficacy. The outcoMeteres froMeter this study will also lay the groundwork for a large placebo-controlled trial of intraarticular UC-derived WJ for syMeterptoMeteratic knee Osteoarthritis. Trial registration: ClinicalTrials.gov NCoMeterputed toMeterography04719793. Registered on 22 January 2021